Doximity, Inc.

NYSE:DOCS 주식 보고서

시가총액: US$5.1b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Doximity 과거 수익 실적

과거 기준 확인 4/6

Doximity은 연평균 39.2%의 비율로 수입이 증가해 온 반면, Healthcare Services 산업은 수입이 증가했으며, 연간 8.3%였습니다. 매출은 연평균 27.5%의 비율로 증가했습니다. Doximity의 자기자본이익률은 16.4%이고 순이익률은 31%입니다.

주요 정보

39.2%

수익 성장률

27.8%

EPS 성장률

Healthcare Services 산업 성장1.7%
매출 성장률27.5%
자기자본 수익률16.4%
순이익31.0%
최근 수익 업데이트31 Mar 2024

최근 과거 실적 업데이트

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Feb 15
We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Recent updates

Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Jun 09
Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

May 04
Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Apr 16
With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Mar 26
Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Feb 15
We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Feb 13
What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Jan 04
Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Dec 14
Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 30
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Sep 25
Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Jul 29
A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Jul 09
Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

The Returns At Doximity (NYSE:DOCS) Aren't Growing

Jun 21
The Returns At Doximity (NYSE:DOCS) Aren't Growing

Doximity: Digital Health Play With Strong Fundamentals

Jun 21

A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Apr 07
A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Mar 20
Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Doximity: Good Business But Extremely Overvalued

Feb 18

Doximity Q3 Earnings: Disappointing Results

Feb 10

Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Dec 25
Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: On The Right Path To Further Consolidate Market Share

Dec 22

Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Dec 04
Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Doximity up 16% after fiscal 2023 Q2 beats, FY revenue range includes consensus

Nov 10

Doximity, down 9%, falls below IPO price

Oct 12

Doximity Appears Well-Positioned But Shares May Be Fully Valued Here

Aug 11

Doximity Non-GAAP EPS of $0.14 beats by $0.03, revenue of $90.6M beats by $0.95M

Aug 04

Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares

Jul 09
Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares

Pair Trade: Going Long Doximity And Short Teladoc

Jul 05

수익 및 비용 분석

Doximity 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

NYSE:DOCS 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
31 Mar 2447514817082
31 Dec 2346813816983
30 Sep 2344812316784
30 Jun 2343711916683
31 Mar 2341911316080
31 Dec 2240211915376
30 Sep 2238414114672
30 Jun 2236214813868
31 Mar 2234413312862
31 Dec 2131710711457
30 Sep 212775710153
30 Jun 21243308847
31 Mar 21207227844
31 Dec 20177146740
31 Mar 20116114632
31 Mar 198614027

양질의 수익: DOCS 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: DOCS 의 현재 순이익 이익률 (31%) 작년보다 높습니다 (26.9%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: DOCS 의 수익은 지난 5년 동안 매년 39.2% 씩 크게 증가했습니다.

성장 가속화: 지난 1년간 DOCS 의 수익 증가율( 30.8% )은 5년 평균( 39.2% 보다 낮습니다. 년도).

수익 대 산업: 지난 1년간 DOCS 수익 증가율( 30.8% )은 Healthcare Services 업계 8.6% 초과했습니다.


자기자본 수익률

높은 ROE: DOCS 의 자본 수익률( 16.4% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기